Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease

Overview of attention for article published in Breast Cancer Research and Treatment, June 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 260 followers.

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease. https://t.co/tfixbZD8NS

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.